Optical coherence tomography imaging of everolimus-eluting bioresorbable vascular scaffold implanted into coronary vein graft at 3-month follow-up A 54-year-old male with stable angina, hypertension, and dyslipidaemia, as well as a history of coronary artery bypass grafting with implantation of two saphenous vein grafts to left anterior descending artery (LAD) (Ao-LAD) and diagonal branch (Ao-D1) 23 years ago. Coronary angiography done because of recurrent angina revealed a chronic total occlusion of the right coronary artery, occlusion of Ao-LAD, and significant stenosis of Ao-D1. Quantitative coronary angiography (QCA) showed 92% stenosis of Ao-D1 with its reference lumen diameter of 3.7 mm, minimal lumen diameter (MLD) of 0.3 mm, and lesion length of 11 mm. After pre-dilatation with semi-complainant balloon 2.5 × 8 mm, an everolimus-eluting bioresorbable vascular scaffold (BVS) ABSORB 3.5 × 12 mm (Abbott, Santa Clara, CA, USA) had been implanted with good angiographic results. Acute angiographic results and QCA post-implantation showed MLD of 3.1 and 15% residual stenosis of SVG. Afterwards, the patient had been scheduled for an intravascular optical coherence (OCT) imaging 3 months after the intervention to monitor Ao-D1 healing. OCT revealed complete apposition, no edge dissection or an excessive neointimal hyperplasia in the BVS. The minimal lumen area was 6.2 mm 2 and the minimal BVS area was 6.7 mm 2 . Moreover, 136 BVS struts were analysed and 71 (52%) of them had been already covered by the neointima. No signs of BVS absorption were detected (Panels A-D, Supplementary material online, Video S1).
This report presents favourable vessel healing after ABSORB implantation to VG in a short-term follow-up. However, further observations are required to monitor the influence of BVS absorption on the VG morphology in a long-term follow-up.
Optical coherence tomography of bioresorbable vascular scaffold implanted into coronary vein graft. Optical coherence tomography (OCT) imaging of ABSORB performed 3 months post its implantation into the Ao-D1, the dashed lines are labelled with numbers that correspond to presented OCT cross sections, dark lines indicate the position of the ABSORB in Ao-D1.
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